Screener
QuidelOrtho Corporation QDEL Latin America — R&D
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by QuidelOrtho Corporation in its filing.
Tagged under the XBRL concept qdel:SegmentInformationResearchAndDevelopmentExpense.
The source filing: QuidelOrtho Corporation’s 10-Q, filed August 7, 2026.
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q3 2026
- Accession
- 0001906324-26-000033
| (In millions) | North America | EMEA | China | JPAC | Latin America | Total |
|---|---|---|---|---|---|---|
| Less (1): | ||||||
| Cost of sales, excluding amortization of intangibles | 116.7 | 44.3 | 28.8 | 43.3 | 38.3 | 271.4 |
| Selling, marketing and administrative | 40.7 | 23.9 | 9.5 | 12.3 | 13.2 | 99.6 |
| Research and development | 0.4 | 0.1 | 0.6 | 0.3 | 0.6 | 2.0 |
| Other expense, net | — | 0.8 | (1.4) | 0.1 | (1.6) | (2.1) |
| Total segment Adjusted EBITDA | $169.6 | $22.1 | $30.3 | $18.3 | $19.7 | 260.0 |
| Reconciliation of segment Adjusted EBITDA | ||||||
| Corporate (2) | (130.7) |
Item 1. Financial Statements (unaudited)
FAQ
- What is QuidelOrtho Corporation's latin america — R&D?
- QuidelOrtho Corporation (QDEL) reported latin america — R&D of $600K in Q2 2026.
- How has QuidelOrtho Corporation's latin america — R&D changed year-over-year?
- QuidelOrtho Corporation's latin america — R&D increased by 20.0% year-over-year, from $500K to $600K.
- What does latin america — R&D mean?
- Reflects the costs incurred for research and development activities specifically allocated to or supporting the Latin American segment's product portfolio. This investment indicates the company's commitment to regional product innovation and adaptation to local clinical requirements.
Ask your AI about QuidelOrtho Corporation's latin america — r&d.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude